NASDAQ:INVA
Innoviva, Inc Stock News
$15.79
+0.440 (+2.87%)
At Close: May 31, 2024
33 Fit Dividend Stocks For Our Times: The August Assortment
04:10pm, Tuesday, 11'th Aug 2020
Kiplinger listed five sets of dividend stocks qualified to survive the COVID-19 pandemic. Barron's weekly added one more.
Russia’s accelerated COVID-19 vaccine greeted with alarm as experts say Phase 3 trial is essential
03:35pm, Tuesday, 11'th Aug 2020
News that Russia has registered the first vaccine to treat COVID-19 before starting and completing Phase 3 trials was greeted with alarm on Tuesday, with...
LiveRamp Holdings, Inc. (RAMP) CEO Scott Howe on Full Year 2021 Results - Earnings Call Transcript
12:10pm, Tuesday, 11'th Aug 2020
LiveRamp Holdings, Inc.(NYSE:RAMP) Full Year 2021 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Lauren Dillard – Chief Communications Officer Scott Howe – Chief Executiv
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2020 Update
07:49am, Tuesday, 11'th Aug 2020
Fisher’s 13F portfolio value increased from $80.64B to $102.5B in Q2 2020. They increased PayPal, Walt Disney, NextEra Energy, UnitedHealth, 3M Company, Intuitive Surgical, Abbott Labs, Starbucks, a
IPO Update: CureVac Readies Plans For U.S. IPO (Pending:CVAC)
04:44pm, Monday, 10'th Aug 2020
CureVac has filed to raise $200 million in a U.S. IPO and another $118 million in a concurrent private placement.
The Never Coming Stock Market Crash - Smart Money Is Still Waiting, Here's What I Do
01:10pm, Monday, 10'th Aug 2020
My article The Coming Stock Market Crash - Smart Money Is Already Ringing The Death Bell was by far my most successful piece on Seeking Alpha.
Dividend Income Summary: Lanny's July 2020 Summary
08:56am, Monday, 10'th Aug 2020
Despite the pandemic from COVID-19, dividend income continues to grow, due to additional investment and reinvestment.
MorphoSys AG (MOR) CEO Jean-Paul Kress on Q2 2020 Results - Earnings Call Transcript
08:46am, Sunday, 09'th Aug 2020
MorphoSys AG (NASDAQ:MOR) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 AM ET Company Participants Anja Pomrehn - Head of IR Jean-Paul Kress - CEO Jens Holstein - CFO Malte Peters - Chief Re
Orchard Therapeutics plc (ORTX) CEO Bobby Gaspar on Q2 2020 Results - Earnings Call Transcript
07:32pm, Saturday, 08'th Aug 2020
Orchard Therapeutics plc (NASDAQ:ORTX) Q2 2020 Results Conference Call August 06, 2020 08:00 AM ET Company Participants Renee Leck - Investor Relations Bobby Gaspar - Chief Executive Officer Frank Tho
Merck KGaA (MKGAF) CEO Stefan Oschmann on Q2 2020 Results - Earnings Call Transcript
07:29pm, Saturday, 08'th Aug 2020
Merck KGaA (OTCPK:MKGAF) Q2 2020 Results Conference Call August 6, 2020 8:00 AM ET Company Participants Constantin Fest - IR Marcus Kuhnert - CFO Stefan Oschmann - CEO Conference Call Participants Mat
Theravance Biopharma's (TBPH) CEO Rick Winningham on Q2 2020 Results - Earnings Call Transcript
03:11pm, Saturday, 08'th Aug 2020
Theravance Biopharma, Inc. (NASDAQ:TBPH) Q2 2020 Earnings Conference Call August 6, 2020 5:00 PM ET Company Participants Gail Cohen – Vice President, Corporate Communications and Investor Relations
Can you spot patients' acidic damage? – Dentistry Online
08:20am, Friday, 07'th Aug 2020
Pronamel from GSK is launching its dedicated resource page highlighting the important role acid plays in your patients' diet.
Tweedy, Browne Fund Q2 2020 Commentary
05:25am, Friday, 07'th Aug 2020
Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pens
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
12:00am, Friday, 07'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 6)
ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction of AditxtScore for COVID-19 to be used in detecting...
Xconomy: GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod
11:49pm, Thursday, 06'th Aug 2020
Patients with advanced multiple myeloma have a new treatment option with the FDA’s approval of a GlaxoSmithKline drug that targets B-cell maturation
